127 related articles for article (PubMed ID: 35420075)
1. A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis.
Ullah A; Chen G; Yibang Z; Hussain A; Shafiq M; Raza F; Liu D; Wang K; Cao J; Qi X
Biomater Sci; 2022 May; 10(10):2650-2664. PubMed ID: 35420075
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.
Ullah A; Wang K; Wu P; Oupicky D; Sun M
Int J Nanomedicine; 2019; 14():2927-2944. PubMed ID: 31118614
[No Abstract] [Full Text] [Related]
3. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
5. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
6. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
7. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
[TBL] [Abstract][Full Text] [Related]
8. Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.
Chen J; Li X; Hu Y; Liu W; Zhou Q; Zhang H; Mu Y; Liu P
Am J Chin Med; 2017; 45(5):1061-1074. PubMed ID: 28659031
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
[TBL] [Abstract][Full Text] [Related]
10. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis.
Asifullah K; Zhou Z; He W; Gao K; Khan MW; Faisal R; Muhammad H; Sun M
Mol Pharm; 2019 Jun; 16(6):2728-2741. PubMed ID: 31070930
[TBL] [Abstract][Full Text] [Related]
12. Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell.
Lin X; Li J; Xing YQ
Int Immunopharmacol; 2019 Jul; 72():330-338. PubMed ID: 31005778
[TBL] [Abstract][Full Text] [Related]
13. Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.
Zhou YN; Sun MY; Mu YP; Yang T; Ning BB; Ren S; Chen JM; Liu P
J Ethnopharmacol; 2014 May; 153(3):659-66. PubMed ID: 24637190
[TBL] [Abstract][Full Text] [Related]
14. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.
Bennett RG; Simpson RL; Hamel FG
World J Gastroenterol; 2017 Jun; 23(22):3999-4006. PubMed ID: 28652653
[TBL] [Abstract][Full Text] [Related]
15. Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
Ma J; Qiu Y; Wang M; Zhang M; Zhao X; Jiang H
Dig Dis Sci; 2019 Sep; 64(9):2570-2580. PubMed ID: 30874989
[TBL] [Abstract][Full Text] [Related]
16. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.
Wang Y; Zhang X; Yang Y; Yang X; Ye B
Mar Drugs; 2015 Aug; 13(8):5201-18. PubMed ID: 26295240
[TBL] [Abstract][Full Text] [Related]
17. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of seed melon extract on CCl
Zhan YY; Wang JH; Tian X; Feng SX; Xue L; Tian LP
J Ethnopharmacol; 2016 Dec; 193():531-537. PubMed ID: 27717904
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis.
Chen G; Zhu Y; Liang X; Wang X; Yu W; Guo J; Zhu L; Ma R
Biomed Res Int; 2020; 2020():8815904. PubMed ID: 33415158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
